Form 4: Penumbra Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Penumbra Inc. Director Harpreet Grewal sold 186 shares of common stock for $312.64 per share, executed under a pre-arranged 10b5-1 trading plan.
Summary
- Harpreet Grewal, a Director of Penumbra Inc. (PEN), reported a sale of common stock.
- The transaction involved the disposition of 186 shares of common stock.
- The shares were sold at a price of $312.64 per share.
- The sale occurred on January 6, 2026.
- Following this transaction, Harpreet Grewal directly owns 8,230 shares of Penumbra common stock.
- The sale was executed pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled, non-discretionary transaction.
Sentiment
Score: 5
Explanation: The transaction is a routine insider sale executed under a pre-arranged 10b5-1 trading plan, which typically does not carry strong positive or negative implications for the company's fundamentals or future prospects.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, which suggests the transaction was pre-scheduled and not based on new, material non-public information.
Negatives
- A director selling shares, even under a 10b5-1 plan, reduces their direct ownership in the company.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance.
Industry Context
This insider transaction report reflects a routine sale by a director and does not provide specific insights into broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: Minimal impact due to the small size and pre-planned nature of the sale by a director.
- Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction report.
Key Dates
| Date | Description |
|---|---|
| 01/06/2026 | Date of transaction (sale of common stock) |
| 01/08/2026 | Date the Form 4 was signed and filed |
Recommendation
holdThis Form 4 reports a routine, pre-scheduled insider sale under a 10b5-1 plan. Such transactions are generally not indicative of a change in the company's fundamental outlook and do not typically warrant a change in investment recommendation based solely on this filing. Investors should consider broader company performance and market conditions.
Keywords
Penumbra, PEN, Form 4, insider trading, stock sale, director, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.